CIUMMO, STEFANIA LIVIA
CIUMMO, STEFANIA LIVIA
DIPARTIMENTO DI MEDICINA E SCIENZE DELL'INVECCHIAMENTO
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival
2021-01-01 Sorrentino, Carlo; D’Antonio, Luigi; Fieni, Cristiano; Ciummo, Stefania Livia; Di Carlo, Emma
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
2022-01-01 Sorrentino, Carlo; D'Antonio, Luigi; Ciummo, Stefania Livia; Fieni, Cristiano; Landuzzi, Lorena; Ruzzi, Francesca; Vespa, Simone; Lanuti, Paola; Lotti, Lavinia Vittoria; Lollini, Pier Luigi; Di Carlo, Emma
Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling
2021-01-01 Sorrentino, Carlo; Ciummo, Stefania Livia; D'Antonio, Luigi; Lanuti, Paola; Abrams, Scott I.; Yin, Zhinan; Lu, Li‐fan; Di Carlo, Emma
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival
2024-01-01 Fieni, C.; Sorrentino, C.; Ciummo, S. L.; Fontana, A.; Lotti, L. V.; Scialis, S.; Calvo Garcia, D.; Caulo, M.; Di Carlo, E.
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival
2023-01-01 D'Antonio, Luigi; Fieni, Cristiano; Ciummo, Stefania Livia; Vespa, Simone; Lotti, Lavinia; Sorrentino, Carlo; Di Carlo, Emma
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome
2021-01-01 Sorrentino, C.; Ciummo, S. L.; D'Antonio, L.; Fieni, C.; Lanuti, P.; Turdo, A.; Todaro, M.; Di Carlo, E.
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways
2023-01-01 Ciummo, Stefania Livia; Sorrentino, Carlo; Fieni, Cristiano; Di Carlo, Emma
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization
2018-01-01 Sorrentino, Carlo; Ciummo, STEFANIA LIVIA; Cipollone, Giuseppe; Caputo, Sara; Bellone, Matteo; Di Carlo, Emma
Nanomedicine for cancer patient-centered care
2024-01-01 Sorrentino, Carlo; Ciummo, Stefania Livia; Fieni, Cristiano; Di Carlo, Emma
Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing
2024-01-01 Fieni, Cristiano; Ciummo, Stefania Livia; Sorrentino, Carlo; Marchetti, Simona; Vespa, Simone; Lanuti, Paola; Lotti, Lavinia Vittoria; Di Carlo, Emma
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival
2019-01-01 Sorrentino, C.; Yin, Z.; Ciummo, S.; Lanuti, P.; Lu, L. -F.; Marchisio, M.; Bellone, M.; Di Carlo, E.
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs
2021-01-01 Ciummo, Stefania Livia; D'Antonio, Luigi; Sorrentino, Carlo; Fieni, Cristiano; Lanuti, Paola; Stassi, Giorgio; Todaro, Matilde; Di Carlo, Emma
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival | 2021 | Sorrentino, Carlo; D’Antonio, Luigi; Fieni, Cristiano; Ciummo, Stefania Livia; Di Carlo, Emma | |
| CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality | 2022 | Sorrentino, Carlo; D'Antonio, Luigi; Ciummo, Stefania Livia; Fieni, Cristiano; Landuzzi, Lorena; Ruzzi, Francesca; Vespa, Simone; Lanuti, Paola; Lotti, Lavinia Vittoria; Lollini, Pier Luigi; Di Carlo, Emma | |
| Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling | 2021 | Sorrentino, Carlo; Ciummo, Stefania Livia; D'Antonio, Luigi; Lanuti, Paola; Abrams, Scott I.; Yin, Zhinan; Lu, Li‐fan; Di Carlo, Emma | |
| Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival | 2024 | Fieni, C.; Sorrentino, C.; Ciummo, S. L.; Fontana, A.; Lotti, L. V.; Scialis, S.; Calvo Garcia, D.; Caulo, M.; Di Carlo, E. | |
| Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival | 2023 | D'Antonio, Luigi; Fieni, Cristiano; Ciummo, Stefania Livia; Vespa, Simone; Lotti, Lavinia; Sorrentino, Carlo; Di Carlo, Emma | |
| Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome | 2021 | Sorrentino, C.; Ciummo, S. L.; D'Antonio, L.; Fieni, C.; Lanuti, P.; Turdo, A.; Todaro, M.; Di Carlo, E. | |
| Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways | 2023 | Ciummo, Stefania Livia; Sorrentino, Carlo; Fieni, Cristiano; Di Carlo, Emma | |
| Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization | 2018 | Sorrentino, Carlo; Ciummo, STEFANIA LIVIA; Cipollone, Giuseppe; Caputo, Sara; Bellone, Matteo; Di Carlo, Emma | |
| Nanomedicine for cancer patient-centered care | 2024 | Sorrentino, Carlo; Ciummo, Stefania Livia; Fieni, Cristiano; Di Carlo, Emma | |
| Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing | 2024 | Fieni, Cristiano; Ciummo, Stefania Livia; Sorrentino, Carlo; Marchetti, Simona; Vespa, Simone; Lanuti, Paola; Lotti, Lavinia Vittoria; Di Carlo, Emma | |
| Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival | 2019 | Sorrentino, C.; Yin, Z.; Ciummo, S.; Lanuti, P.; Lu, L. -F.; Marchisio, M.; Bellone, M.; Di Carlo, E. | |
| The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs | 2021 | Ciummo, Stefania Livia; D'Antonio, Luigi; Sorrentino, Carlo; Fieni, Cristiano; Lanuti, Paola; Stassi, Giorgio; Todaro, Matilde; Di Carlo, Emma |